title: In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
authors.affiliation: Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France, Integrative Physiology of the Brain Arousal Systems, Centre de Recherche en Neurosciences de Lyon, INSERM U1028-CNRS UMR 5292, Faculté de Médecine, Université Claude Bernard Lyon 1, Lyon, France Hospices Civils de Lyon, Institut de Parasitologie Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France.
authors.forename: Damien
authors.initials: D
authors.lastname: Dupont
authors.forename: François
authors.initials: F
authors.lastname: Peyron
mesh_terms: D000962:Antimalarials; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D011739:Pyrimethamine; D013413:Sulfadoxine; D014125:Toxoplasmosis, Congenital
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine